Eli Lilly’s blockbuster GLP-1 drug tirzepatide is finally back on track in the US after two years of intermittent shortages ...

Kurma Partners has closed the first part of its latest biotech-focused fund, following a pair of M&A exits for drug ...

A Louisiana judge on Monday defended a new state law that keeps drugmakers from imposing certain restrictions around the ...

Septerna is joining biotech's IPO on-deck circle, preparing for a public offering with two other startups that have recently ...

Gilead announced Wednesday that it will allow certain drug manufacturers to make and sell a generic version of its ...

BioNTech became a big name in biopharma thanks to its Pfizer-partnered Covid-19 vaccine. It's betting that artificial ...

The Centers for Medicare & Medicaid Services wants earlier and more flexible communication with drugmakers during the next ...

Teladoc's chief operating officer has resigned due to an executive reshuffle, a few months after the company named a new CEO.

After an already brutal year for its Medicare Advantage business, major health insurer Humana said it’s taken a hit to its ...

The European Medicines Agency is looking to speed up its drug review timelines, following a recent report showing how ...

Frazier Life Sciences has added more than $630 million to its evergreen public fund, the firm said Wednesday. The long-only ...

Senators may be back in their districts gearing up for next month's elections, but that isn't stopping them from questioning ...